Long-term imatinib diminishes ovarian reserve and impacts embryo quality.
Wael SalemJacqueline R HoIrene WooSue A InglesKarine ChungRichard J PaulsonLynda K McGinnisPublished in: Journal of assisted reproduction and genetics (2020)
This pilot study indicates that long-term TKI treatments may have significant impact on ovarian reserve and embryo developmental capacity. More studies are needed in other model systems to determine the long-term impact of TKIs in patients. Knowing the potential effects of chemotherapeutics on reproductive outlook is critical for quality of life and more research is needed.